Budget Impact Model of New Antiretroviral Biotechnology Medicines for Treatment of HIV/AIDS Patients in Bulgaria

Dimitrova, Maria; Petrova, Guenka; Cervenjakova, Tatiana; Jancheva, Nina; Stefanova, Mona; Manova, Manoela; Savova, Alexandra; Stoimenova, А.

doi:10.5504/bbeq.2011.0053

Cited by 3 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The average price of ART for a patient with HIV per year in Bulgaria is €8,139. At the same time, the prices are lower in other EU Member States (with significantly higher gross domestic product per capita rates) including Italy, the Netherlands, Spain, and the United Kingdom (Dimitrova et al 2011;Dimitrova et al 2013;ECDC 2017a).…”

Section: Drug and Treatment Costsmentioning

confidence: 99%

Tackling the World's Fastest-Growing HIV Epidemic: More Efficient HIV Responses in Eastern Europe and Central Asia

Zhao¹,

Benedikt²,

Wilson³

2020

View full text Add to dashboard Cite

This work is a product of the staff of The World Bank with external contributions. The findings, interpretations, and conclusions expressed in this work do not necessarily reflect the views of The World Bank, its Board of Executive Directors, or the governments they represent. The World Bank does not guarantee the accuracy of the data included in this work. The boundaries, colors, denominations, and other information shown on any map in this work do not imply any judgment on the part of The World Bank concerning the legal status of any territory or the endorsement or acceptance of such boundaries.Nothing herein shall constitute or be considered to be a limitation upon or waiver of the privileges and immunities of The World Bank, all of which are specifically reserved.

show abstract

Section: Drug and Treatment Costsmentioning

confidence: 99%